Italy Mice Model Market Size, Share,Trends, Growth Analysis Report, 2030

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Italy Mice Model Market analysis

Part of: Mice Model Market (Global)

The Italy Mice Model Market was valued at $31.5 Million in 2025 and projected to reach to $47.1 Million by 2030, representing a compound annual growth rate of 8.4%. Italy's mice model market is poised for sustained expansion through 2030, driven by increased pharmaceutical R&D spending and strengthened academic research capabilities.

Italy Mice Model Market (2025-2030) : Size and Share

CAGR of

USD Million

Italy Mice Model Market Trends and Insights

This 8.4% compound annual growth rate reflects Italy's strengthening position in biomedical research and pharmaceutical development across Europe.
Italy's investment in life sciences infrastructure and academic research institutions continues to drive demand for preclinical models. The Italian mice model market benefits from robust pharmaceutical R&D activities and increasing collaboration between Italian universities and international biotech firms.
Italy's regulatory environment and research funding mechanisms support the adoption of advanced animal models in drug discovery and development.
By 2030, Italy is expected to solidify its role as a key hub for preclinical research in the European mice model sector. Growth in Italy's market is underpinned by rising demand for personalized medicine research and the expansion of contract research organizations (CROs) specializing in preclinical services.
Italy's commitment to reducing animal testing through refined methodologies while maintaining research quality positions the country favorably within the evolving European regulatory landscape..

Key Market Statistics

CAGR (2025-2030) 8.4% CAGR
Market Size, 2025 ~USD 31.5 Million
Forecast, 2030 ~USD 47.1 Million
Country Italy

Italy Mice Model Market Overview

Market Valuation Growth :

Italy's mice model market is valued at $31.5 million in 2025, with projections reaching $47.1 million by 2030, representing a robust 8.4% CAGR driven by increased biomedical research investments.

Research Infrastructure Expansion :

Italy's strengthening life sciences infrastructure and world-class academic research institutions are catalyzing demand for advanced mice models in pharmaceutical development and preclinical testing.

European Biomedical Hub :

Italy's strategic position within Europe's biomedical research ecosystem positions it as a key market for mice model suppliers, with growing collaboration between universities and pharmaceutical companies.

Regulatory and Innovation Support :

Italian government initiatives supporting life sciences innovation and EU regulatory frameworks are encouraging pharmaceutical companies to establish research operations, boosting mice model demand.

Italy Mice Model Market Dynamics

The country's commitment to life sciences infrastructure development and its integration within European research networks create favorable conditions for market growth.
Italian universities and research institutions are increasingly adopting advanced preclinical testing methodologies, elevating demand for specialized mice models.
Collaborations between public research entities and private pharmaceutical firms are expected to accelerate market penetration and innovation in disease modeling applications..

Related Ecosystem

Biotechnology

Top Technologies

Reagents
Polymerase Chain Reaction (PCR)
Stem Cells
Assay Kits
Flow Cytometers

Top Companies

Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corporation
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.

Key Takeaways

Italy's mice model market is valued at $31.5 million in 2025 and is forecast to reach $47.1 million by 2030, representing an 8.4% CAGR.
Italy's pharmaceutical and biotech sectors are driving increased demand for preclinical research models and advanced animal testing services.
Italy's academic institutions and CROs are expanding their capabilities in mice model research, supporting drug discovery and personalized medicine initiatives.
Italy's regulatory framework emphasizes ethical animal research practices, positioning the country as a responsible leader in European preclinical research.

Mice Model Market Report Scope

Report Metric	Details
Base Year	2025
Fastest Growing Segment	SERVICES (Model Type & Service)
Forecast Period	2025�2030
Growth Rate	CAGR of 10% from 2025 to 2030
Largest Segment	MODEL TYPE (Model Type & Service)
Market Size Base Year (Billions)	~USD 1.7 (2025)
Revenue Forecast (Billions)	~USD 2.74 (2030)
Segments Covered	Model Type & Service, Type, Technology, Application, Therapeutic Area, End User

Italy Mice Model Market Report Segmentation

6 segment dimensions are covered across the global market.

By Model Type & Service

Model Type
Services

By Type

Breeding Services
Cryopreservation Services
Genetically Engineered Mice
Hybrid/Congenic Mice
Inbred Mice
Other Services
Outbred Mice
Quarantine Services
Rederivation Services

By Technology

Crispr/Cas9
Embryonic Stem Cell Injections
Microinjections
Nuclear Transfer Technique
Other Technologies

By Application

Drug Discovery & Development
Personalized Medicine
Research Applications

By Therapeutic Area

Cardiovascular Diseases
Immunology
Metabolic Diseases
Neurology
Oncology
Other Therapeutic Areas

By End User

Academic & Research Institutes
Contract Research Organizations (Cros) & Contract Development And Manufacturing Organizations (Cdmos)
Pharmaceutical & Biotechnology Companies

ITALY: MICE MODEL TYPE MARKET, BY END USER, 2023�2030

Segment	2023	2024	2025	2026	2027	2028	2029	2030	CAGR (%)
ACADEMIC & RESEARCH INSTITUTES	9.8	10.5	11.5	12.5	13.6	14.6	15.6	16.6	7.7
CROS & CDMOS	5.1	5.5	6.1	6.7	7.3	7.9	8.4	9	8.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES	11.6	12.7	14	15.5	17	18.4	20	21.5	9
TOTAL	26.5	28.8	31.5	34.7	37.8	40.9	44	47.1	8.4

Target Audience

Pharmaceutical Companies : Italian and European pharma firms need Italy-specific market data to optimize preclinical research budgets, identify local suppliers, and plan R&D facility investments.
Contract Research Organizations (CROs) : CROs operating in Italy require detailed market insights to assess service demand, benchmark pricing strategies, and identify growth opportunities in preclinical testing services.
Mice Model Suppliers : Vendors and breeders need Italy market intelligence to understand customer base composition, competitive positioning, and demand drivers for specialized mouse strains and models.
Academic Research Institutions : Italian universities and research centers use market data to justify funding requests, benchmark procurement practices, and align research capabilities with industry demand.
Investment and Strategy Consultants : Consultants advising life sciences clients need Italy-specific market analysis to support due diligence, market entry strategies, and investment decision-making in the region.

Key Companies in the Italy Mice Model Market

Company	HQ	Ownership	Strongest segments
HORIZON DISCOVERY GROUP PLC	United Kingdom	Private Company	Screening,Research Reagents,Diagnostics,
LABORATORY CORPORATION OF AMERICA HOLDINGS	United States	Public Company	Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women�s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D),
CHARLES RIVER LABORATORIES	United States	Public Company	Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions,
THE JACKSON LABORATORY	United States	Foundation/Charitable Institution	Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models,
INOTIV	United States	Public Company	Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software,
JSR CORPORATION	Japan	Private Company	Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support),
BIOCYTOGEN	China	Public Company	Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales),
SHANGHAI MODEL ORGANISMS CENTER, INC.	China	Public Company	Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis),
TRANS GENIC INC.	Japan	Public Company	Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis,
HARBOUR BIOMED	China	Public Company	Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio),
GENOWAY	France	Public Company	Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom),
GEMPHARMATECH	China	Public Company	Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services,
VIVO BIO TECH LTD.	India	Public Company	In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services,

HORIZON DISCOVERY GROUP PLC

Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.

LABORATORY CORPORATION OF AMERICA HOLDINGS

Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.

CHARLES RIVER LABORATORIES

Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.

THE JACKSON LABORATORY

The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.

INOTIV

Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.

JSR CORPORATION

JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.

BIOCYTOGEN

Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.

SHANGHAI MODEL ORGANISMS CENTER, INC.

Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.

TRANS GENIC INC.

Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.

HARBOUR BIOMED

Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.

GENOWAY

Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.

GEMPHARMATECH

GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.

VIVO BIO TECH LTD.

Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.

Reasons to Buy this Report

Market-Specific Growth Data : Access Italy-specific valuation metrics, CAGR analysis, and 5-year forecasts to accurately assess market opportunities and competitive positioning within the Italian biomedical research sector.
Regulatory and Infrastructure Insights : Understand Italy's unique regulatory environment, research institution landscape, and government support mechanisms that directly influence mice model demand and supplier strategies.
Competitive Landscape Analysis : Identify key players, market consolidation trends, and competitive dynamics specific to Italy's mice model market to inform strategic partnerships and market entry decisions.
End-User Demand Segmentation : Gain detailed insights into Italian pharmaceutical companies, academic research centers, and CROs driving mice model adoption, enabling targeted sales and marketing strategies.
Investment and Expansion Planning : Leverage Italy-focused market intelligence to evaluate expansion opportunities, facility investments, and resource allocation decisions within the Italian life sciences ecosystem.

Frequently asked questions

What is the current size of Italy's mice model market?

Italy's mice model market was valued at $31.5 million in 2025 and is expected to grow to $47.1 million by 2030.

What is the growth rate of Italy's mice model market?

Italy's mice model market is growing at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.

Which sectors are driving growth in Italy's mice model market?

Italy's pharmaceutical R&D, biotech innovation, and academic research institutions are the primary drivers of growth in the mice model market.

How does Italy's mice model market compare to other European countries?

Italy maintains a significant position in Europe's mice model market, supported by strong research infrastructure and regulatory compliance with EU standards.

What role do CROs play in Italy's mice model market?

Contract research organizations in Italy provide specialized preclinical services, including mice model development and testing, supporting both domestic and international pharmaceutical clients.

RESEARCH METHODOLOGY

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Data Triangulation

The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.

Stakeholders

Manufacturers & Distributors of Mice Models
CROs & CDMOs
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Market Research & Consulting Firms
Researchers & Scientists
Regulatory Authorities & Institutes

Report Objectives

To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.

Get the Full Mice Model Market Report

Full forecast, segment splits, and company analysis for all Mice Model Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)